176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
15.64%
Growth of 15.64% while MRVL shows flat revenue. Bruce Berkowitz would examine growth quality advantage.
17.02%
Cost growth of 17.02% while MRVL maintains flat costs. Bruce Berkowitz would investigate efficiency gap.
13.58%
Growth of 13.58% while MRVL shows flat gross profit. Bruce Berkowitz would examine quality advantage.
-1.78%
Margin decline while MRVL shows 0.00% expansion. Joel Greenblatt would examine competitive position.
15.78%
R&D change of 15.78% while MRVL maintains spending. Bruce Berkowitz would investigate effectiveness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
7.29%
Operating expenses change of 7.29% while MRVL maintains costs. Bruce Berkowitz would investigate control.
14.24%
Total costs change of 14.24% while MRVL maintains costs. Bruce Berkowitz would investigate control.
No Data
No Data available this quarter, please select a different quarter.
3.37%
D&A change of 3.37% while MRVL maintains D&A. Bruce Berkowitz would investigate efficiency.
20.44%
EBITDA change of 20.44% while MRVL is flat. Bruce Berkowitz would examine quality.
4.15%
Margin change of 4.15% while MRVL is flat. Bruce Berkowitz would examine quality.
22.90%
Income change of 22.90% while MRVL is flat. Bruce Berkowitz would examine quality.
6.28%
Margin change of 6.28% while MRVL is flat. Bruce Berkowitz would examine quality.
89.71%
Other expenses change of 89.71% while MRVL maintains costs. Bruce Berkowitz would investigate control.
25.08%
Income change of 25.08% while MRVL is flat. Bruce Berkowitz would examine quality.
8.16%
Margin change of 8.16% while MRVL is flat. Bruce Berkowitz would examine quality.
24.71%
Tax expense change of 24.71% while MRVL maintains burden. Bruce Berkowitz would investigate strategy.
25.25%
Income change of 25.25% while MRVL is flat. Bruce Berkowitz would examine quality.
8.31%
Margin change of 8.31% while MRVL is flat. Bruce Berkowitz would examine quality.
50.00%
EPS change of 50.00% while MRVL is flat. Bruce Berkowitz would examine quality.
25.00%
Diluted EPS change of 25.00% while MRVL is flat. Bruce Berkowitz would examine quality.
-15.63%
Share count reduction while MRVL shows 0.00% change. Joel Greenblatt would examine strategy.
3.57%
Diluted share change of 3.57% while MRVL is stable. Bruce Berkowitz would verify approach.